News of the company Karo Bio - Huddinge, Sweden

Article 1 to 4 out of 4 concerning Karo Bio AB

Karo Bio announces Merck has entered clinical development with estrogen receptor compound (09/14/2006)
Karo Bio announced that an estrogen receptor compound discovered as part of its research collaboration with Merck & Co., Inc. has entered Phase I clinical development. The collaboration with Merck began in November 1997 with the objective of ...

more information
�
Karo Bio and Wyeth extend research collaboration (08/09/2006)
Karo Bio announced that Wyeth and Karo Bio extended their atherosclerosis collaboration for an additional year until August 31, 2007. The primary objective of the extension is to characterize back up compounds and to further evaluate additional ...

more information
�
Karo Bio and Wyeth Extend Research Collaboration (08/17/2005)
Wyeth and Karo Bio have agreed to extend the research term of their atherosclerosis collaboration for an additional year until August 31, 2006 with the intention of selecting candidate drugs for development.Karo Bio entered into a three year ...

more information
�
Clinical Trials Initiated and Significant Milestone Reached in the Collaboration Between Karo Bio and Merck & Co., Inc. (01/26/2005)
Clinical trials have been initiated for the most advanced compound in the drug discovery and development collaboration between Merck & Co., Inc. and Karo Bio. The advancement of this compound, in clinical development to address an important unmet ...

more information
�

Current News RSS